AMPE (AMPE) Stock Price & Analysis
AMPE (AMPE) rose 0.00% to USD 0.18 as of June 10, 2026 at 05:54 UTC, according to Nexqual real-time market data.
AMPE last closed at USD 0.18; the session ranged USD 0.01–0.01 on volume of 334 shares. Market capitalization is $207,884, with a 52-week range of USD 0–0.64 (PNK). Source: Nexqual, June 10, 2026 at 05:54 UTC.
Key Statistics (as of June 10, 2026 at 05:54 UTC)
| Price | USD 0.18 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.18 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.64 |
| Volume | 334 shares |
| Market Cap | $207,884 |
| Exchange | PNK |
Technical Analysis (AMPE)
Nexqual's technical model rates AMPE "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 05:54 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.41 (neutral) |
| vs SMA50 | Above (USD 0.16) |
| MACD | 0.01 (positive) |
Analyst Ratings (AMPE)
Wall Street analysts rate AMPE "None", per Nexqual as of June 10, 2026 at 05:54 UTC.
| Consensus Rating | None |
|---|
Earnings (AMPE)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-06-30 | USD -3 vs est -6 ▲ beat |
| 2022-03-31 | USD -6 vs est -6 ▲ beat |
| 2021-12-31 | USD -12 vs est -6 ▼ miss |
| 2021-09-30 | USD -6 vs est -6 ▲ beat |
Source: Nexqual, June 10, 2026 at 05:54 UTC.
Financials & Fundamentals (AMPE)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -113.96% |
| Debt / Equity | 13.42 |
| Current Ratio | 2.41 |
| Total Cash | $4.12M |
| Total Debt | $451,000 |
| Free Cash Flow | $-5.37M |
Source: Nexqual, June 10, 2026 at 05:54 UTC.
Financial Health Score (AMPE)
Nexqual rates AMPE's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:54 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $4M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$9M |
| Efficiency | Critical — ROE -114%, ROA -61.6% |
Ownership (AMPE)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.04% |
| Shares Outstanding | 1.14M |
| Float | 1.12M |
| Short % of Float | +2.94% |
Source: Nexqual, June 10, 2026 at 05:54 UTC.
Leadership (AMPE)
AMPE is led by Michael A. Martino (age 68), CEO, CFO, General Secretary & Director, per Nexqual as of June 10, 2026 at 05:54 UTC.
| CEO, CFO, General Secretary & Director | Michael A. Martino (age 68) |
|---|---|
| Founder & Chairman of Scientific Advisory Board | David Bar-Or (age 76) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATNM | Actinium Pharmaceuticals, Inc. | USD 1.01 | ▼ 6.48% |
| OGEN | Oragenics Inc. | USD 0.6 | ▲ 1.69% |
| TLPH | Talphera, Inc. | USD 0.82 | ▲ 4.56% |
| CANF | Can-Fite Biopharma Ltd | USD 2.91 | ▼ 5.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:54 UTC. This page is informational and not investment advice.